[1] Medina-Caliz I, Robles-Diaz M, Garcia-Muñoz B, et al. Definition and risk factors for chronicity following acute idiosyncratic drug-induced liver injury.J Hepatol,2016,65:532-542.
[2] Yu YC, Mao YM, Chen CW, et al.CSH guidelines for the diagnosis and treatment of drug-induced liver injury.Hepatol Int,2017,11:221-241.
[3] Kleiner DE.The histopathological evaluation of drug-induced liver injury.Histopathology, 2017,70:81-93.
[4] 中华医学会肝病学分会药物性肝病学组.药物性肝损伤诊治指南.中华肝脏病杂志,2015,23:810-820.
[5] 陆人杰,朱珊梅,唐风雷,等.424例药物性肝损伤临床特征及相关危险因素分析.肝脏,2017,22:235-239.
[6] Navarro VJ, Khan I, Björnsson, et al.Liver injury from herbal and dietary supplements. Hepatol,2017,65:363-373.
[7] Ahmad J, Odin JA.Epidemiology and Genetic Risk Factors of Drug Hepatotoxicity.Clin Liver Dis,2017,21:55-72.
[8] 中华中医药学会肝胆病分会, 中华中医药学会中成药分会.中草药相关肝损伤临床诊疗指南.中国中药杂志,2016,41:835-843.
[9] Bjornsson ES,Hoofnagle JH.Categorization of drugs implicated in causing liver injury: critical assessment based on published case reports.Hepatol,2016,63:590-603. |
